Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (17)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Coupes, B. M.
Right arrow Articles by Mallick, N. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coupes, B. M.
Right arrow Articles by Mallick, N. P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (1993) 8: 397-401
© 1993 European Renal Association-European Dialysis and Transplant Association

research-article

The temporal relationship between urinary C5b-9 and C3dg and clinical parameters in human membranous nephropathy

B. M. Coupes, S. P. Kon, P.E.C. Brenchley, C. D. Short and N. P. Mallick

Department of Renal Medicine, Manchester Royal Infirmary UK

Correspondence and offprint requests to: Correspondence and offprint requests to: Dr B. M. Coupes, Department of Renal Medicine, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL, UK

We have previously reported that urinary excretion of the complement activation products C3dg and C5b–9 in human membranous nephropathy (MN) correlated with clinical outcome in a cross-sectional analysis. We report here the results of a retrospective longitudinal study of the temporal relationship between urinary C3dg and C5b–9 excretion and clinical parameters. A group of 23 adult patients with biopsyproven MN were studied over a mean time period per patient of 3.5 years. Freshly voided urine samples were collected regularly; C3dg and C5b–9 were measured by ELISA (mean number of samples per patient=13).

During the period of the study, nine patients with declining renal function (group A) were treated with a standard steroid regimen. Serum creatinine had improved or stabilized in seven of these patients at the end of treatment. All nine patients were excreting C3dg and C5b–9 before treatment. Six other patients with declining renal function (group B) were not treated with steroids because of clinical contraindications. Serum creatinine continued to increase during the study in four of these six patients. C3dg and C5b–9 were present in the urine samples of these six patients on the majority of dates tested.

Eight patients maintained stable renal function during the study (group C), either normal (6 patients) or impaired (2 patients). Of these patients, six were consistently negative for urinary C3dg and C5b–9 despite persistent proteinuria, and one patient who was initially positive became negative within 15 months, and remained negative for the rest of the study period. One patient was positive on one of 12 occasions tested. These results suggest that urinary complement activation products indicate ongoing active glomerular damage and may prove to be important determinants for the introduction and monitoring of therapy.

Keywords: complement activation; membranous nephropathy; urinary excretion


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Am. Soc. Nephrol.Home page
M. Nangaku, S. J. Shankland, and W. G. Couser
Cellular Response to Injury in Membranous Nephropathy
J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1195 - 1204.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.